Entrada Therapeutics Inc.

11.30
-0.64 (-5.36%)
At close: Mar 03, 2025, 3:59 PM
11.33
0.27%
After-hours: Mar 03, 2025, 04:00 PM EST

Entrada Therapeutics Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 101.21M 67.6M 45.16M 291.06M 39.05M 16.84M
Short-Term Investments 318.79M 284.37M 143.56M n/a n/a n/a
Long-Term Investments n/a n/a 3.95M n/a n/a n/a
Other Long-Term Assets 4.23M 6.74M 5.21M 872K 541K -801K
Receivables 3.68M 5.88M n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a
Other Current Assets 16.36M 11.92M 21.16M 7.64M 904K 593K
Total Current Assets 440.04M 369.77M 209.88M 298.7M 39.95M 17.44M
Property-Plant & Equipment 82.05M 92.68M 33.02M 6.26M 3.04M 801K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 86.28M 99.42M 42.18M 7.13M 3.58M 801K
Total Assets 526.32M 469.19M 252.06M 305.83M 43.53M 18.24M
Account Payables 4.26M 3.28M 5.99M 706K 1.6M 710K
Deferred Revenue 13.65M 132.26M n/a n/a n/a n/a
Short-Term Debt 7.56M 14.93M 16.81M n/a n/a n/a
Other Current Liabilities 13.34M 11.32M -830K 6.01M 1.76M 1.21M
Total Current Liabilities 39.48M 158.8M 21.97M 6.72M 3.36M 1.92M
Long-Term Debt 51.65M 60.32M 17.53M n/a n/a n/a
Other Long-Term Liabilities 6.51M n/a n/a 396K n/a 31.84M
Total Long-Term Liabilities 58.16M 68.04M 17.53M 396K 81.66M 31.84M
Total Liabilities 97.64M 226.83M 39.5M 7.12M 85.02M 33.76M
Total Debt 59.21M 68.23M 25.94M n/a n/a n/a
Common Stock 4K 3K 3K 3K 1K 1K
Retained Earnings -129.34M -194.97M -188.28M -93.67M -42.51M -15.99M
Comprehensive Income -43K 195K -2.06M -305.83M -81.66M -31.82M
Shareholders Equity 428.68M 242.36M 212.55M 298.72M -41.49M -15.52M
Total Investments 318.79M 284.37M 143.56M n/a n/a n/a